Menu

 

Web Directory - All Sites Sorted » Health Beauty and Fitness » Medicine


 


Sponsored

 

Latest News

Conditions of Growth, Economic Analysis - Research Report on Onyx Pharmaceuticals, Inc. and Qiagen NV
HONG KONG-- - Today, www.EquityLeader.com introduced research coverage of Onyx Pharmaceuticals, Inc. and Qiagen NV . Full research reports are available to readers at: www.EquityLeader.com/index.php?sm1=ONXX&sm2=QGEN ... Fri, 10 Feb 2012 06:00:00 -0800

Ironwood Pharmaceuticals Prices Public Offering of Common Stock
Ironwood Pharmaceuticals, Inc. announced today the pricing of an underwritten public offering of 5,250,000 shares of its Class A common stock at a price of $15.09 per share to the public. Thu, 09 Feb 2012 19:53:00 -0800

Ampio Pharmaceuticals Reports Full-Year 2011 Financial Results and Milestone Highlights for 2011
GREENWOOD VILLAGE, Colo., Feb. 9, 2012 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE - News) ("Ampio" or the "Company"), a company that discovers and develops new uses for previously ... Thu, 09 Feb 2012 14:00:00 -0800

Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results
Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, today reported its consolidated financial results for the fourth quarter and full year 2011, and Thu, 09 Feb 2012 13:00:00 -0800

Cadence Pharmaceuticals CEO Ted Schroeder to Present at the Leerink Swann 2012 Global Healthcare Conference on ...
SAN DIEGO, Feb. 9, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX - News), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally ... Thu, 09 Feb 2012 13:00:00 -0800

Forbes Earnings Preview: Watson Pharmaceuticals
Leading up to Watson Pharmaceuticals' (WPI) announcement of its fourth quarter earnings on Tuesday, February 14, 2012, analysts have become more bullish as expectations have improved over the past month from $1.61 per share to the current projection of earnings of $1.75 per share. Thu, 09 Feb 2012 11:58:49 -0800

Watson Pharmaceuticals Inc. Fourth Quarter Earnings Sneak Peek
Here's what you need to know for the upcoming earnings release ... Thu, 09 Feb 2012 11:20:16 -0800

Momenta Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year End 2011
CAMBRIDGE, Mass. -- Momenta Pharmaceuticals, Inc. , a biotechnology company specializing in the characterization and engineering of complex drugs, today reported its financial results for the fourth quarter ... Thu, 09 Feb 2012 05:30:00 -0800

NPS Pharmaceuticals to Report 2011 Financial Results
NPS Pharmaceuticals, Inc. announced today that it will report its 2011 financial results on Wednesday, February 15, 2012 at approximately 4:30 p.m. ET. The press release will be followed by a conference call and webcast at 5:00 p.m. Wed, 08 Feb 2012 13:10:00 -0800

APP Pharmaceuticals Announces Launch of Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP
APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States. Tue, 07 Feb 2012 22:01:00 -0800

Website Directory Sort by: Hits | Alphabetical

Features

Top 5 Web Hosts
(Largest)


Top 5 Favorite Web Hosts

   1. HostGator
   2. LunarPages
   3. Yahoo! Web Hosting
   4. HostMonster
   5. BlueHost